中山醫學大學機構典藏 CSMUIR:Item 310902500/21583
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 17938/22957 (78%)
造访人次 : 7401140      在线人数 : 242
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.csmu.edu.tw:8080/ir/handle/310902500/21583


    题名: Statins improve the long-term prognosis in patients who have survived sepsis.
    作者: Sung-Yuan Hu;Ming-Shun Hsieh;Tzu-Chieh Lin;Shu-Hui Liao;Vivian Chia-Rong Hsieh;Jen-Huai Chiang;Yan-Zin Chang
    关键词: 3-hydroxy-3-methylglutaryl-coenzyme-A inhibitors, sepsis
    日期: 2019-04
    上传时间: 2021-08-11T03:35:22Z (UTC)
    摘要: Most patients diagnosed with sepsis died during their first episode, with the long-term survival rate upon post-sepsis discharge being low. Major adverse cardiovascular events and recurrent infections were regarded as the major causes of death. No definite medications had proven to be effective in improving the long-term prognosis. We aimed to examine the benefits of statins on the long-term prognosis of patients who had survived sepsis.

    Between 1999 and 2013, a total of 220,082 patients who had been hospitalized due to the first episode of sepsis were included, with 134,448 (61.09%) of them surviving to discharge. The surviving patients who were subsequently prescribed statins at a concentration of more than 30 cumulative Defined Daily Doses (cDDDs) during post-sepsis discharge were defined as the users of statin.

    After a propensity score matching ratio of 1:5, a total of 7356 and 36,780 surviving patients were retrieved for the study (statin users) and comparison cohort (nonstatin users), respectively. The main outcome was to determine the long-term survival rate during post-sepsis discharge.

    HR with 95% CI was calculated using the Cox regression model to evaluate the effectiveness of statins, with further stratification analyses according to cDDDs.

    The users of statins had an adjusted HR of 0.29 (95% CI, 0.27–0.31) in their long-term mortality rate when compared with the comparison cohort. For the users of statins with cDDDs of 30–180, 180–365, and >365, the adjusted HRs were 0.32, 0.22, and 0.16, respectively, (95% CI, 0.30–0.34, 0.19–0.26, and 0.12–0.23, respectively), as compared with the nonstatins users (defined as the use of statins <30 cDDDs during post-sepsis discharge), with the P for trend <.0001. In the sensitivity analysis, after excluding the surviving patients who had died between 3 and 6 months after post-sepsis discharge, the adjusted HR for the users of statins remained significant (0.35, 95% CI 0.32–0.37 and 0.42, 95% CI 0.39–0.45, respectively).

    Statins may have the potential to decrease the long-term mortality of patients who have survived sepsis. However, more evidence, including clinical and laboratory data, is necessary in order to confirm the results of this observational cohort study.
    Trial registration: CMUH104-REC2-115.
    URI: https://ir.csmu.edu.tw:8080/handle/310902500/21583
    關聯: Medicine (Baltimore). 2019 Apr; 98(17): e15253.
    显示于类别:[醫學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    medi-98-e15253.pdf429KbAdobe PDF248检视/开启


    检视Licence

    SFX Query

    在CSMUIR中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈